THE NOVEL BISPECIFIC CD47‐CD19 ANTIBODY TG‐1801 POTENTIATES THE ACTIVITY OF UBLITUXIMAB‐UMBRALISIB (U2) DRUG COMBINATION IN PRECLINICAL MODELS OF B‐NHL

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.322-323
Main Authors: Normant, E., Ribeiro, M.L., Reyes, D., Miskin, H.P., Sportelli, P., Weiss, M.S., Bosch, F., Roue, G.
Format: Article
Language:English
Subjects:
Antibodies
CD19 antigen
Monoclonal antibodies
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.133_2630